India is the third-largest country in the world for medication production. The Indian pharmaceutical sector produces one of every two pills consumed worldwide, one of every two vaccinations given, and 40% of all generic medications imported from India. As a result, India itself is one of the prospective suppliers of generic medications as the need for them grows daily globally. India's generic drug market, which had a value of USD 24.53 billion in 2022, is anticipated to expand at a consistent CAGR of 6.97% throughout the course of the projected period.
Ikris Pharma Network is a global wholesaler and exporter of FDA-approved pharmaceuticals and biopharmaceuticals from the US, EMEA, and other regions, making us top pharmaceutical supplier. We provide name-brand, generic, and OTC (over-the-counter) US/EMEA/other FDA products to domestic and foreign hospitals, government agencies, pharmaceutical firms, contract research organizations (CRO), retail pharmacies, and other authorized distributors.
read more..